IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 59 filers reported holding IKENA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,719,205 | -31.7% | 397,045 | +3.4% | 0.00% | – |
| Q2 2023 | $2,518,082 | +1117.4% | 383,854 | +540.3% | 0.00% | – |
| Q1 2023 | $206,838 | -23.4% | 59,953 | -40.9% | 0.00% | – |
| Q4 2022 | $270,006 | +141.1% | 101,506 | +221.7% | 0.00% | – |
| Q3 2022 | $112,000 | -42.9% | 31,553 | -28.7% | 0.00% | – |
| Q2 2022 | $196,000 | -92.1% | 44,256 | -89.1% | 0.00% | – |
| Q1 2022 | $2,468,000 | -42.2% | 404,602 | +18.8% | 0.00% | – |
| Q4 2021 | $4,271,000 | +155.4% | 340,614 | +157.1% | 0.00% | – |
| Q3 2021 | $1,672,000 | +55.8% | 132,468 | +73.3% | 0.00% | – |
| Q2 2021 | $1,073,000 | – | 76,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $62,928,000 | 5.78% |
| Omega Fund Management, LLC | 2,249,123 | $28,204,000 | 3.99% |
| CHI Advisors LLC | 814,756 | $10,217,000 | 3.39% |
| BVF INC/IL | 1,798,371 | $22,552,000 | 0.82% |
| Artal Group S.A. | 1,549,513 | $19,431,000 | 0.53% |
| Orbimed Advisors | 2,933,941 | $36,792,000 | 0.47% |
| Logos Global Management LP | 299,853 | $3,760,000 | 0.39% |
| HealthCor Management, L.P. | 287,621 | $3,607,000 | 0.20% |
| RA Capital Management | 750,000 | $9,405,000 | 0.17% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,081,309 | $13,560,000 | 0.07% |